Study Of SU011248 Administered On A Continuous Daily Dosing Schedule In Patients With Gastrointestinal Stromal Tumor

Clinical trial NCT00137449 · COMPLETED

Trial details

NCT number: NCT00137449
Sponsor: Pfizer
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Gastrointestinal Stromal Tumors

Start date: 2005-09-01
Primary completion: 2008-04-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.